- Patent Title: Function suppression type of genetically-modified rhodocytin mutant
-
Application No.: US15590268Application Date: 2017-05-09
-
Publication No.: US10208096B2Publication Date: 2019-02-19
- Inventor: Tomoyuki Sasaki , Toshiaki Shirai , Katsue Inoue
- Applicant: UNIVERSITY OF YAMANASHI
- Applicant Address: JP Yamanashi
- Assignee: University of Yamanashi
- Current Assignee: University of Yamanashi
- Current Assignee Address: JP Yamanashi
- Agency: Maier & Maier, PLLC
- Priority: JP2016-094203 20160509
- Main IPC: C07K14/00
- IPC: C07K14/00 ; A61K38/00 ; C07K14/46 ; C07K14/705
Abstract:
According to the present invention, a mutant rhodocytin lacking platelet aggregation ability is provided. According to the present invention, a pharmaceutical composition including a mutant rhodocytin lacking platelet aggregation ability is provided. According to the present invention, there is provided a method for inhibiting platelet aggregation by a platelet aggregating substance, including administering a pharmaceutical composition including a mutant rhodocytin lacking platelet aggregation ability to a subject in need thereof.
Public/Granted literature
- US20170320924A1 FUNCTION SUPPRESSION TYPE OF GENETICALLY-MODIFIED RHODOCYTIN MUTANT Public/Granted day:2017-11-09
Information query
